BACKGROUND: Juvenile nasopharyngeal angiofibroma (JNA) is a rare, highly vascularized neoplasm of the nasopharynx that affects boys and young men. The underlying dysregulated molecular mechanisms remain unclear. The participation of angiogenic growth factors has been suggested, but few studies have been published. OBJECTIVES: To evaluate the expression and localization of vascular endothelial growth factor (VEGF), proliferating cells, and vessel density in JNA. STUDY DESIGN: Immunohistochemical examination of 10 consecutive JNAs (8 primary tumors and 2 recurrent tumors). METHODS: Paraffin-embedded and cryopreserved JNA samples were included. VEGF-, CD31-, and Ki67-specific antibodies were applied and visualized using light microscopy. Vascularization was determined by counting CD31-positive vessels. Proliferating and VEGF-expressing vessels as well as stromal cells were quantified by the same method. Patients' age at the time of surgery and tumor stage were correlated with the immunohistochemical data. RESULTS: All tumors were heavily vascularized, but major differences were noted between the samples. About half of the vessels were proliferating (Ki67 positive) and half of the Ki67-positive cells were also VEGF positive. The tumor stroma was VEGF positive in 8 of 10 samples and proliferating in 5 of these 8. The 5 samples with both VEGF- and Ki67-positive stroma showed high vessel densities. No correlation was observed between age or tumor stage and vessel density, VEGF expression, or Ki67 expression. CONCLUSIONS: In JNA, VEGF is frequently expressed by stromal cells and vessels and is associated with proliferation and increased vessel density. We suggest the promotion of vascularization by VEGF, but the involvement of androgens in JNA angiogenesis still needs to be analyzed.
BACKGROUND:Juvenile nasopharyngeal angiofibroma (JNA) is a rare, highly vascularized neoplasm of the nasopharynx that affects boys and young men. The underlying dysregulated molecular mechanisms remain unclear. The participation of angiogenic growth factors has been suggested, but few studies have been published. OBJECTIVES: To evaluate the expression and localization of vascular endothelial growth factor (VEGF), proliferating cells, and vessel density in JNA. STUDY DESIGN: Immunohistochemical examination of 10 consecutive JNAs (8 primary tumors and 2 recurrent tumors). METHODS:Paraffin-embedded and cryopreserved JNA samples were included. VEGF-, CD31-, and Ki67-specific antibodies were applied and visualized using light microscopy. Vascularization was determined by counting CD31-positive vessels. Proliferating and VEGF-expressing vessels as well as stromal cells were quantified by the same method. Patients' age at the time of surgery and tumor stage were correlated with the immunohistochemical data. RESULTS: All tumors were heavily vascularized, but major differences were noted between the samples. About half of the vessels were proliferating (Ki67 positive) and half of the Ki67-positive cells were also VEGF positive. The tumor stroma was VEGF positive in 8 of 10 samples and proliferating in 5 of these 8. The 5 samples with both VEGF- and Ki67-positive stroma showed high vessel densities. No correlation was observed between age or tumor stage and vessel density, VEGF expression, or Ki67 expression. CONCLUSIONS: In JNA, VEGF is frequently expressed by stromal cells and vessels and is associated with proliferation and increased vessel density. We suggest the promotion of vascularization by VEGF, but the involvement of androgens in JNA angiogenesis still needs to be analyzed.
Authors: Robert Schuon; Jürgen Brieger; Ulf R Heinrich; Yeduha Roth; Witold Szyfter; Wolf J Mann Journal: Eur Arch Otorhinolaryngol Date: 2006-12-20 Impact factor: 2.503
Authors: Tran Le; Jacob New; Joel W Jones; Shireen Usman; Sreeya Yalamanchali; Ossama Tawfik; Larry Hoover; Dan E Bruegger; Sufi Mary Thomas Journal: Int Forum Allergy Rhinol Date: 2017-07-14 Impact factor: 3.858
Authors: Román Carlos; Lester D R Thompson; Ana Carolina Netto; Luiz Gustavo Garcia Santos Pimenta; Jeane de Fátima Correia-Silva; Carolina Cavaliéri Gomes; Ricardo Santiago Gomez Journal: Head Neck Pathol Date: 2008-07-01
Authors: Suely Nonogaki; Heloisa G A Campos; Ossamu Butugan; Fernando A Soares; Flávia Regina Rotea Mangone; Humberto Torloni; M Mitzi Brentani Journal: Exp Ther Med Date: 2010-08-26 Impact factor: 2.447
Authors: Suvi Renkonen; Jaana Hagström; Jyrki Vuola; Mika Niemelä; Matti Porras; Sanna-Maria Kivivuori; Ilmo Leivo; Antti A Mäkitie Journal: Eur Arch Otorhinolaryngol Date: 2010-09-17 Impact factor: 2.503
Authors: Chris M van der Loos; Lorine B Meijer-Jorna; Marloes E C Broekmans; Hanneke P H M Ploegmakers; Peter Teeling; Onno J de Boer; Allard C van der Wal Journal: J Histochem Cytochem Date: 2010-02 Impact factor: 2.479
Authors: Joel W Jones; Shireen Usman; Jacob New; Andrew Holcomb; Sumedha Gunewardena; Ossama Tawfik; Larry Hoover; Daniel Bruegger; Sufi Mary Thomas Journal: Otolaryngol Head Neck Surg Date: 2018-04-10 Impact factor: 3.497